000
| 01874cam 2200385zi 4500 |
---|
001 | 9.887043 |
---|
003 | CaOODSP |
---|
005 | 20221107171606 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 200507t20202020onc ob f000 0 eng d |
---|
020 | |a9780660349121 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH139-16/2020E-PDF |
---|
245 | 00|aExplanatory notes for drug establishments on the preparation of a site master file. |
---|
246 | 17|aExplanatory notes for drug establishments on the preparation of a site master file (GUI-0005) version 6 |
---|
264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2020. |
---|
264 | 4|c©2020 |
---|
300 | |a1 online resource (15 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Notes explicatives à l'intention des établissements de produits pharmaceutiques sur la préparation d'un dossier d'établissement. |
---|
500 | |a"GUI-0005." |
---|
500 | |a"July 17, 2020." |
---|
500 | |a"Pub.: 200019." |
---|
500 | |aIssued also in HTML format. |
---|
504 | |aIncludes bibliographical references (page 15). |
---|
650 | 0|aPharmaceutical industry|xLicenses|zCanada. |
---|
710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
---|
775 | 08|tNotes explicatives à l'intention des établissements de produits pharmaceutiques sur la préparation d'un dossier d'établissement.|w(CaOODSP)9.887047 |
---|
856 | 40|qPDF|s1.10 MB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H139-16-2020-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/annex-1-explanatory-notes-industry-preparation-site-master/document.html |
---|